1. Home
  2. ELUT vs CHMI Comparison

ELUT vs CHMI Comparison

Compare ELUT & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • CHMI
  • Stock Information
  • Founded
  • ELUT 2015
  • CHMI 2012
  • Country
  • ELUT United States
  • CHMI United States
  • Employees
  • ELUT N/A
  • CHMI N/A
  • Industry
  • ELUT Medical Specialities
  • CHMI Real Estate Investment Trusts
  • Sector
  • ELUT Health Care
  • CHMI Real Estate
  • Exchange
  • ELUT Nasdaq
  • CHMI Nasdaq
  • Market Cap
  • ELUT 84.3M
  • CHMI 89.2M
  • IPO Year
  • ELUT 2020
  • CHMI 2013
  • Fundamental
  • Price
  • ELUT $1.96
  • CHMI $2.69
  • Analyst Decision
  • ELUT Strong Buy
  • CHMI Hold
  • Analyst Count
  • ELUT 2
  • CHMI 1
  • Target Price
  • ELUT $8.00
  • CHMI N/A
  • AVG Volume (30 Days)
  • ELUT 27.8K
  • CHMI 239.1K
  • Earning Date
  • ELUT 08-06-2025
  • CHMI 08-07-2025
  • Dividend Yield
  • ELUT N/A
  • CHMI 22.47%
  • EPS Growth
  • ELUT N/A
  • CHMI N/A
  • EPS
  • ELUT N/A
  • CHMI N/A
  • Revenue
  • ELUT $23,711,000.00
  • CHMI $27,506,000.00
  • Revenue This Year
  • ELUT $20.10
  • CHMI N/A
  • Revenue Next Year
  • ELUT $85.89
  • CHMI $54.92
  • P/E Ratio
  • ELUT N/A
  • CHMI N/A
  • Revenue Growth
  • ELUT N/A
  • CHMI 19.59
  • 52 Week Low
  • ELUT $1.61
  • CHMI $2.34
  • 52 Week High
  • ELUT $5.12
  • CHMI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 47.39
  • CHMI 43.05
  • Support Level
  • ELUT $1.82
  • CHMI $2.64
  • Resistance Level
  • ELUT $2.16
  • CHMI $2.75
  • Average True Range (ATR)
  • ELUT 0.25
  • CHMI 0.08
  • MACD
  • ELUT -0.03
  • CHMI 0.01
  • Stochastic Oscillator
  • ELUT 23.81
  • CHMI 59.38

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: